Prenatal control of Hb Bart’s hydrops fetalis: a two-year experience at a mainland Chinese hospital

Abstract α-Thalassemia is a common inherited disease in southern China. The severest form is Hb Bart’s hydrops fetalis, in which the affected fetuses almost always die in utero or shortly after birth, and the mothers are at high risk for severe morbidity. Therefore, this condition should be controlled, especially prenatally. In this study, we reported on a two-year experience in prenatal control of Hb Bart’s hydrops fetalis at a mainland Chinese hospital. Totally, 573 pregnancies at risk for Hb Bart’s hydrops fetalis were referred and different prenatal procedures were offered depending on the gestational age at presentation. One hundred fifty-two affected fetuses were diagnosed prenatally; among these, only half presented in early gestation, and were terminated in time. Although our prenatal program has successfully prevented the birth of children with severe thalassemia, it does not show a satisfactory outcome, considering the gestational age when an affected pregnancy is terminated.

[1]  C. Liao,et al.  Nonimmune Hydrops Fetalis Diagnosed during the Second Half of Pregnancy in Southern China , 2007, Fetal Diagnosis and Therapy.

[2]  Xiang-min Xu,et al.  Carrier screening for α‐ and β‐thalassemia in pregnancy: the results of an 11‐year prospective program in Guangzhou Maternal and Neonatal hospital , 2005 .

[3]  G. Luo,et al.  The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening , 2004, Journal of Clinical Pathology.

[4]  T. Tongsong,et al.  Sonographic Markers of Hemoglobin Bart Disease at Midpregnancy , 2004, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[5]  D. Chui,et al.  Hydrops Fetalis Caused by α-Thalassemia: An Emerging Health Care Problem , 1998 .

[6]  Chin-peng Lee,et al.  EARLY ULTRASOUND PREDICTION OF PREGNANCIES AFFECTED BY HOMOZYGOUS α‐THALASSAEMIA‐1 , 1997 .

[7]  C. P. Lee,et al.  A new strategy for prenatal diagnosis of homozygous alpha(0)-thalassemia. , 2006, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[8]  W. Piyamongkol,et al.  Prenatal eradication of Hb Bart's hydrops fetalis. , 2001, The Journal of reproductive medicine.

[9]  C. P. Lee,et al.  Prenatal ultrasonographic prediction of homozygous type 1 alpha-thalassemia at 12 to 13 weeks of gestation. , 1999, American journal of obstetrics and gynecology.

[10]  C. P. Lee,et al.  Early ultrasound prediction of pregnancies affected by homozygous alpha-thalassaemia-1. , 1997, Prenatal diagnosis.